Salute e Benessere

GUERBET : H1 2024 revenue.

H1 2024 revenue Half-yearly activityH1 revenue: €419.2m, up 11.8% at CER 1, including an acceleration in Q2 (+14.5%)This acceleration was driven by continued catch-up in the Americas, the normalisation of orders in France and MRI salesAnnual targets confirmedRevenue: expected growth of over 8% like-for-like and at CERProfitability: restated EBITDA margin rate 2higher than in 2021 (14.4%)Villepinte, 25 July 2024, 5.45 pm:Guerbet (FR0000032526 GBT), a global...
Nasdaq GlobeNewswire
25/07/2024

European regulatory authority adopts a positive opinion for an update of the…

Bagsværd, Denmark, 25 July 2024– Novo Nordisk today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy ®(semaglutide 2.4 mg) label to reflect data from the SELECT cardiovascular outcomes trial, demonstrating a risk reduction of major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal heart attack (myocardial infarction) or non-fatal stroke in...
Nasdaq GlobeNewswire
25/07/2024

Press Release: Online availability of Sanofi's half-year financial report for…

Online availability of Sanofi's half-year financial report for 2024Paris, July 25, 2024. Sanofi announces that its half-year financial report for the period ending June 30, 2024 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.This document may be found on the company's corporate website:www.sanofi.comand downloaded from the “Investors” page,...
Nasdaq GlobeNewswire
25/07/2024

Next-generation Sequencing Services Market to be Worth $24.44 billion by 2031-…

The growth of this market is mainly attributed to the reduced cost of NGS procedures, the development and approval of new targeted therapies, the rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, the high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant…
PR Newswire
25/07/2024

Hair Extension Market to be dominated by North America and expected to reach…

Get your Sample PDF:https://www.stellarmr.com/report/req_sample/Hair-Extension-Market/2084 Get your Sample PDF: https://www.stellarmr.com/report/req_sample/Hair-Extension-Market/2084 Competitive Landscape The global hair extension market is competitive with several players including Great Lengths ( Italy ),Balmain Hair Couture( France ), Hairdreams ( Austria ), Bellami Hair ( USA ),Luxy Hair( Canada ), Easihair Pro ( USA ), SocapUSA( USA ),Cinderella Hair(UK),...
PR Newswire
25/07/2024

Digital Biomarkers Market Size to Hit USD 43.3 Billion by 2034, Projected a…

The digital biomarkers market is experiencing significant growth driven by the increasing prevalence of chronic diseases and advancements in digital health technologies. Digital biomarkers refer to objective, quantifiable physiological data collected and analyzed through digital devices or platforms. These biomarkers provide valuable insights into an individual's health status, disease progression, and response to treatment. The digital biomarkers market is experiencing significant growth...
PR Newswire
25/07/2024

Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its…

"We are proud to have achieved ISO 13485:2016 certification at such an early point in our company's history," said Yuling Luo, Ph.D., Chairman, Founder and CEO of Alamar "This certification is a testament to the hard work and dedication of our entire team. It demonstrates our commitment to maintaining the highest standards of quality and safety in our products, ensuring that we meet the needs of our customers and the regulatory requirements of the medical device industry."…
PR Newswire
25/07/2024

Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024)

Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024) Attachment 2024 Ipsen Half-Year Financial Report
Nasdaq GlobeNewswire
25/07/2024

A New Era for Healthcare in Kazakhstan: Unveiling Astana Genetic Center…

The AGC laboratory, located at the National Center for Biotechnology of Kazakhstan, is equipped with the latest DNA sequencing and genomic data analysis equipment. It aims to serve as a vital center for conducting tests that will enhance the health of the Kazakhstani population. The AGC laboratory, located at the National Center for Biotechnology ofKazakhstan, is equipped with the latest DNA sequencing and genomic data analysis equipment. It aims to serve as a vital center for conducting...
PR Newswire
25/07/2024

New Studies Validate the Value of Brainomix AI Technology Across US Stroke…

The FDA-cleared Brainomix 360 Stroke platform is powered by state-of-the-art AI algorithms that provide real-time interpretation of brain scans to aid treatment and transfer decisions for stroke patients, with the aim of enabling more patients to receive the right treatment, in the right place, at the right time. DrMichalis Papadakis , CEO and Co-Founder of Brainomix, said: "The studies presented this week at SNIS symbolize our ongoing commitment to scientific excellence and...
PR Newswire
25/07/2024

AC Immune's ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for…

AC Immune's ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer's Disease Treatment of first randomized person with preclinical AD expected this quarterPhase 2b ReTain trial is fully funded and conducted by development partnerLausanne, Switzerland, July 25, 2024– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that its active-immunotherapy candidate,...
Nasdaq GlobeNewswire
25/07/2024

Collateral Ligament Stabilizer System Market is Projected to Reach USD 4.9…

Continuous improvements in medical technology, such as minimally invasive surgical techniques and better implant materials, enhance the effectiveness and appeal of these systems. The trend towards personalized medicine is leading to the development of customized stabilizer systems tailored to individual patient needs, improving outcomes. Continuous improvements in medical technology, such as minimally invasive surgical techniques and better implant materials, enhance the effectiveness and...
PR Newswire
25/07/2024

Phenylketonuria Treatment Market to Reach $1.62 Billion by 2034, with 7.8% CAGR…

Advancements in phenylketonuria treatment technologies, including new gene therapy approaches, enzyme replacement therapies, and innovative medical food formulations, are significantly progressing. These developments enhance patient compliance and treatment effectiveness, expanding the market size for phenylketonuria treatments. Advancements in phenylketonuria treatment technologies, including new gene therapy approaches, enzyme replacement therapies, and innovative medical food formulations,...
PR Newswire
25/07/2024

Thyseed and BASF Announce Strategic Partnership to Drive High-quality Growth in…

At the event, Mr. Wang traced Thyseed's history in the infant feeding products sector since its establishment in 2016, highlighting the company's unwavering commitment to its "Design from Love" product philosophy, which places user needs and experiences at the forefront of all innovations. Thyseed's introduction of transition feeding bottles, with sales topping five million units, illustrates its robust market presence and the strong trust it has cultivated among consumers. At the…
PR Newswire
25/07/2024

Clinical Data Analytics Market Size to Reach US$ 614.7 billion by 2034: Seizing…

The global clinical data analytics market is witnessing significant growth driven by several key factors. One primary factor contributing to this growth is the increasing incidence of chronic diseases worldwide. Chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders are placing a substantial burden on healthcare systems globally. The global clinical data analytics market is witnessing significant growth driven by several key factors. One primary factor...
PR Newswire
25/07/2024

Blood Transfusion Diagnostics Market to Attain a Valuation of US$ 7.7 Billion by…

The rising global prevalence of blood disorders, such as anemia, hemophilia, and leukemia, necessitates the need for accurate and reliable diagnostic tests to assess blood compatibility and identify potential risks associated with transfusions. The rising global prevalence of blood disorders, such as anemia, hemophilia, and leukemia, necessitates the need for accurate and reliable diagnostic tests to assess blood compatibility and identify potential risks associated with transfusions. ...
PR Newswire
25/07/2024

Providence St. Joseph Hospital Performs World's First Spine Surgery Using…

FOR IMMEDIATE RELEASEProvidence St. Joseph Hospital Performs World's First Spine Surgery Using eCential Robotics' Open Spine Robot, with Spineart Compatible Implants ORANGE, Calif. July 25, 2024– Providence St. Joseph Hospital announced it has successfully performed the world's first robotic spinal surgery using a new open spine platform byeCential Roboticsto implant aSpineartmedical device.eCential Robotics, a surgical robotics company which developed the open surgical...
Nasdaq GlobeNewswire
25/07/2024

Kaerus Bioscience Announces Initiation of Phase 1 Clinical Trial for its Novel…

“Kaerus' BK modulator program is a potential game-changer in field of therapeutics development for Fragile X syndrome,” declared Ring, adding that, “Our lead BK modulator KER-0193 was developed to specifically address a breakdown in brain function uniquely tied to the genetics of Fragile X syndrome.”“The start of our Phase 1 program for KER-0193 represents an exciting milestone for Kaerus, culminating over 5 years of R&D investment in BK channel modulator discovery and enabled by...
Nasdaq GlobeNewswire
25/07/2024

Orion publishes Half-Year Financial Report for January–June 2024 and holds a…

ORION CORPORATIONPRESS RELEASE25 JULY 2024 at 11.00 EEST Orion publishes Half-Year Financial Report for January–June 2024 and holds a webcast on 8 August 2024 Orion will publish Half-Year Financial Report for January–June 2024 on Thursday, 8 August 2024 at approximately 12.00 noon EEST. The report and related presentation material will be available on the company's website at www.orion.fi/en/investors after publishing. Webcast and conference call A webcast and a conference call...
Nasdaq GlobeNewswire
25/07/2024

SIBIONICS Secures MoHAP Product Marketing Authorization Approval for Its GS1 CGM…

In conjunction with this approval, SIBIONICS also announced a strategic partnership with Pharmaworld Store as their exclusive distributor for the GS1 CGM System in the UAE. This collaboration will leverage Pharmaworld Store's extensive distribution network and market expertise to ensure that the GS1 CGM System reaches healthcare providers and patients across the region effectively. In conjunction with this approval, SIBIONICS also announced a strategic partnership with Pharmaworld Store as...
PR Newswire
25/07/2024

Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent…

The initiation of the Phase 1 clinical trial follows Ariceum's submission of a Clinical Trial Authorisation (CTA) application to the UK's Medicines and Healthcare products Regulatory Agency (MHRA) in December 2023 and subsequent approval received from the MHRA in February 2024. The trial has commenced at UCLH, with other sites due to open in the UK and EU later this year. The dose escalation study will be followed by expansion cohorts at a recommended dose in monotherapy and in combination with…
PR Newswire
25/07/2024

Orisha will be on stage in Paris Retail Week with brand new Fashion and Unified…

The new portfolio also includes a new repair module as part of our groundbreaking ReCommerce offering, leveraging Ginkoia's expertise in the area of repair and rental capabilities. The ReCommerce offering will be further enhanced in near future releases by complementary new modules for product rental and second-hand sales, showing Orisha's strong commitment to bringing sustainability to retail thanks to its unique ReCommerce suite of solutions. A value already demonstrated in retailers such as…
PR Newswire
25/07/2024

Implantica announces continuing progress in modular PMA application to FDA for…

Based on this approach, the company does not anticipate any significant impact on the overall timeline. Implantica will provide an update within the next 1-2 months. Based on this approach, the company does not anticipate any significant impact on the overall timeline. Implantica will provide an update within the next 1-2 months. Implantica's CEO, Dr.Peter Forsellsays, "We are passionate about the progress of our PMA submission to FDA and are pleased with the positive feedback received...
PR Newswire
25/07/2024

Groupe Casino: TotalEnergies and Casino renew their partnership for supplying…

Press release 25 July 2024 TotalEnergies and Casino renew their partnership for supplying over 1,000 service stations in France Casino Group and TotalEnergies have announced the renewal of their strategic partnership for supplying more than 1,000 service stations in France. The new agreement, consolidating a partnership of over 20 years between the two companies, will come into force on 1 October 2024 for a duration of five years 1.The partnership includes:A nationwide presence:...
Nasdaq GlobeNewswire
25/07/2024
Altri  Comunicati